PELIZZARI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 1.222
EU - Europa 174
AS - Asia 108
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.508
Nazione #
US - Stati Uniti d'America 1.221
IT - Italia 59
CN - Cina 42
VN - Vietnam 29
BE - Belgio 22
DE - Germania 22
UA - Ucraina 22
IE - Irlanda 21
IN - India 15
SG - Singapore 15
GB - Regno Unito 9
IR - Iran 7
CZ - Repubblica Ceca 6
RU - Federazione Russa 5
EG - Egitto 2
RO - Romania 2
SE - Svezia 2
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
EU - Europa 1
FI - Finlandia 1
FR - Francia 1
NO - Norvegia 1
Totale 1.508
Città #
Chandler 172
Fairfield 134
Ashburn 123
Ann Arbor 111
Seattle 64
Houston 58
Woodbridge 50
Wilmington 49
Cambridge 41
New York 34
Dong Ket 29
Beijing 27
Princeton 26
Brussels 22
Dublin 21
San Diego 15
Redmond 14
Dearborn 13
Singapore 13
Jacksonville 12
Ogden 11
Martignacco 9
Washington 8
Leawood 7
Ardabil 6
Boardman 6
Dallas 6
Brno 5
Augusta 4
Des Moines 4
Los Angeles 4
San Mateo 4
Trieste 4
Udine 4
Caserta 3
Jinan 3
Munich 3
Nanjing 3
Norwalk 3
Scafati 3
Cairo 2
Clifton 2
Edinburgh 2
Hyderabad 2
Milan 2
Phoenix 2
Redwood City 2
Sagrado 2
Asti 1
Bangalore 1
Boston 1
Bucharest 1
Chengdu 1
Florence 1
Fuzhou 1
Grafing 1
Helsinki 1
Kunming 1
Langfang 1
Melfi 1
Mortegliano 1
Nanchang 1
Nantong 1
Naples 1
Paris 1
Prague 1
Romans 1
Rutigliano 1
San Francisco 1
San Remo 1
Shenzhen 1
Toronto 1
Trento 1
Tuenno 1
Venezia 1
Wenzhou 1
Wuhan 1
Totale 1.173
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 118
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 105
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 97
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 89
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 80
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 79
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 75
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 75
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 67
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 61
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 61
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 54
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 43
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 41
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 39
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic 37
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 36
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 34
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach 33
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 32
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 32
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 30
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 25
Totale 1.589
Categoria #
all - tutte 7.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020345 0 15 10 25 20 26 24 38 79 57 37 14
2020/2021423 24 28 59 46 36 8 19 49 13 28 53 60
2021/2022261 22 28 0 5 6 3 17 16 2 34 102 26
2022/2023336 32 49 5 42 39 68 1 27 44 5 16 8
2023/2024205 19 7 9 8 38 79 0 5 15 4 1 20
2024/202519 14 5 0 0 0 0 0 0 0 0 0 0
Totale 1.589